TR-O870043 - 1-oxo-fexofenadine-d10-methyl-ester | 154477-55-1
Sorry, no product with reference TR-O870043 been found, but please check out the following similar products:
Fexofenadine
CAS:Formula:C32H39NO4Purity:≥ 98.0%Color and Shape:White to beige powderMolecular weight:501.66Fexofenadine
CAS:<p>Fexofenadine, a non-sedating antihistamine, treats allergies like hay fever and urticaria.</p>Formula:C32H39NO4Purity:99.35%Color and Shape:White To Off-White SolidMolecular weight:501.66Fexofenadine
CAS:Controlled Product<p>Applications The active metabolite of Terfenadine (T114500), a H1-histamine receptor antagonist.<br>References Garteiz, D.A., et al.: Arzneim.-Forsch., 32, 1185 (1982), Rampe, D., et al.: Mol. Pharmacol., 44, 1240 (1993), Obradovic, T., et al.: Pharm. Res., 24, 318 (2007),<br></p>Formula:C32H39NO4Color and Shape:Off-WhiteMolecular weight:501.66Fexofenadine
CAS:<p>Fexofenadine is a selective histamine H1 receptor antagonist that has been shown to be effective in the treatment of allergic rhinitis. It is well tolerated and does not have any significant drug interactions. Fexofenadine is metabolized by cytochrome P450 (CYP) enzymes and undergoes extensive first-pass metabolism. This means that it should not interact with CYP inhibitors such as ketoconazole or cimetidine, but may increase the effects of CYP inducers such as phenobarbital or rifampin. Fexofenadine has been shown to inhibit the activity of human multidrug resistance protein 1 (MDR1) and P-glycoprotein (P-gp).</p>Purity:Min. 95 Area-%Color and Shape:White Off-White PowderMolecular weight:501.66 g/molFexofenadine Hydrochloride
CAS:Formula:C32H39NO4·HClPurity:>98.0%(T)(HPLC)Color and Shape:White to Almost white powder to crystalMolecular weight:538.13Fexofenadine hydrochloride
CAS:<p>H-1 receptor antagonist</p>Formula:C32H40ClNO4Color and Shape:White to pale cream, PowderMolecular weight:538.13Fexofenadine hydrochloride
CAS:Fexofenadine hydrochlorideFormula:C32H39NO4HClPurity:99.2%Color and Shape:Off-WhiteMolecular weight:537.26459Fexofenadine (2-(4-{1-Hydroxy-4-[4-(hydroxydiphenylmethyl)piperidin-1-yl]butyl}phenyl)-2-methylpropanoic acid dihydrate)
CAS:Compounds containing an unfused pyridine ring in the structure, nesoiFormula:C32H39NO4·2H2OColor and Shape:White Solid Crystalline PowderMolecular weight:537.30904Fexofenadine Hydrochloride
CAS:<p>Compounds containing an unfused pyridine ring in the structure, nesoi</p>Formula:C32H39NO4·HClColor and Shape:White Off-White PowderMolecular weight:501.28791Fexofenadine Related Compound A (2-(4-{4-[4-(Hydroxydiphenylmethyl)piperidin-1-yl]butanoyl}phenyl)-2-methylpropanoic acid)
CAS:Compounds containing an unfused pyridine ring in the structure, nesoiFormula:C32H37NO4Color and Shape:White PowderMolecular weight:499.27226Fexofenadine Related Compound B (2-(3-{1-Hydroxy-4-[4-(hydroxydiphenylmethyl)piperidin-1-yl]butyl}phenyl)-2-methylpropanoic acid hydrochloride monohydrate)
Compounds containing an unfused pyridine ring in the structure, nesoiFormula:C32H39NO4·HCl·H2OColor and Shape:White PowderMolecular weight:556.14Fexofenadine Related Compound C (4-[4-(Hydroxydiphenylmethyl)piperidin-1-yl]-1-(4-isopropylphenyl)butan-1-ol hydrochloride)
CAS:Compounds containing an unfused pyridine ring in the structure, nesoiFormula:C31H39NO2·HClColor and Shape:White PowderMolecular weight:493.27476Fexofenadine Olefin (2-(4-(4-(4-(diphenylmethylene)piperidin-1-yl)-1-hydroxybutyl)phenyl)-2-methylpropanoic acid)
CAS:Compounds containing an unfused pyridine ring in the structure, nesoiFormula:C32H37NO3Color and Shape:White Off-White SolidMolecular weight:483.27734










